Page last updated: 2024-10-24

chlorambucil and BOOP

chlorambucil has been researched along with BOOP in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Chlorambucil was discontinued and an open lung procedure was performed with complete excision of the pulmonary lesion."2.42Bronchiolitis obliterans organizing pneumonia following chlorambucil treatment for chronic lymphocytic leukemia. ( Arkoumani, E; Kalambokis, G; Stefanou, D; Tsianos, E, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kalambokis, G1
Stefanou, D1
Arkoumani, E1
Tsianos, E1

Reviews

1 review available for chlorambucil and BOOP

ArticleYear
Bronchiolitis obliterans organizing pneumonia following chlorambucil treatment for chronic lymphocytic leukemia.
    European journal of haematology, 2004, Volume: 73, Issue:2

    Topics: Aged; Biopsy; Chlorambucil; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Disease-Free

2004